Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: South Korea

Dongbu Bio-Health Care Securities Investment Trust 1 - Equity

+ Add to Watchlist

6170104:KS

1,089.68 KRW 2.10 0.19%

As of 02:38:32 ET on 03/03/2015.

Snapshot for Dongbu Bio-Health Care Securities Investment Trust 1 - Equity (6170104)

Year To Date: +15.99% 3-Month: +15.75% 3-Year: +7.38% 52-Week Range: 912.26 - 1,148.43
1-Month: +8.40% 1-Year: +18.18% 5-Year: +9.99% Beta vs KOSPI: 0.55

Mutual Fund Chart for 6170104

No chart data available.
  • 6170104:KS 1,089.68
  • 1M
  • 1Y
Interactive 6170104 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 6170104

Dongbu Bio-Health Care Securities Investment Trust 1 (Equity) is an open-end fund incorporated in South Korea. The Fund's objective is to achieve capital gains and current income. The Fund invests at least 50% of its total assets in Bio-Health Care stocks.

Inception Date: 11-03-2009 Telephone: 82-2-787-3700
Managers: YONG-NAM HAN
Web Site: www.dongbuam.co.kr

Fundamentals for 6170104

NAV (on 2015-03-03) 1,089.68
Assets (M) (on 2015-03-03) 41,400.71
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 6170104

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-11-03) 103.96
Dividend Yield (ttm) 9.54

Fees & Expenses for 6170104

Front Load -
Back Load -
Current Mgmt Fee 0.72
Redemption Fee -
12b1 Fee -
Expense Ratio 1.29

Top Fund Holdings for 6170104

Filing Date: 09/30/2014
Name Position Value % of Total
HLB Inc 181,588 1,162,163,200 6.339%
JVM Co Ltd 18,063 1,116,293,400 6.089%
Naturalendo Tech Co Ltd 22,472 1,020,228,800 5.565%
Vieworks Co Ltd 25,642 903,880,500 4.930%
Chongkundang Holdings Corp 15,132 892,788,000 4.870%
Seegene Inc 24,024 887,286,400 4.840%
Chong Kun Dang Pharmaceutical 10,889 833,008,500 4.544%
InBody Co Ltd 34,162 811,347,500 4.426%
Bioneer Corp 69,497 684,545,450 3.734%
Chabiotech Co Ltd 55,387 667,413,350 3.641%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil